Dawning Information Industry (603019.SH) plans to issue convertible bonds to raise up to 8 billion yuan.
Zhongke Shuguang (603019.SH) disclosed a plan to issue convertible corporate bonds to unspecified objects. The company plans to issue convertible bonds to raise a total amount of funds not exceeding 8 billion yuan (including the principal). The initial conversion price shall not be lower than the average stock trading price of the company for the 20 trading days prior to the announcement date of the prospectus and the average stock trading price of the company for the previous trading day.
Dawning Information Industry (603019.SH) disclosed a plan to issue convertible corporate bonds to unspecified investors. The company intends to issue convertible bonds to raise a total of no more than 8 billion yuan (including par value), with an initial conversion price not lower than the average trading price of the company's stock for the twenty trading days before the announcement date of the prospectus and the previous trading day.
The total amount of funds raised from this issuance, after deducting issuance expenses, will be used for projects focusing on artificial intelligence, including advanced computational power cluster systems, next-generation high-performance AI training and promotion integrated machines, and domestic advanced storage system projects.
Related Articles
Pre-market report on A-shares | Stock exchange optimization of refinancing signals three major signals Rare earth product prices accelerate rise

Highlights of securities morning meeting | Insurance performance outlook for 2025: Full year profit and NBV are expected to continue high growth

INSILICO (03696) has reached collaboration agreements with CMS worth tens of millions of Hong Kong dollars in the research and development of multiple drugs in the central nervous system and autoimmune disease fields.
Pre-market report on A-shares | Stock exchange optimization of refinancing signals three major signals Rare earth product prices accelerate rise
Highlights of securities morning meeting | Insurance performance outlook for 2025: Full year profit and NBV are expected to continue high growth

INSILICO (03696) has reached collaboration agreements with CMS worth tens of millions of Hong Kong dollars in the research and development of multiple drugs in the central nervous system and autoimmune disease fields.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


